Skip to main content
Clinical Trials/NCT02637726
NCT02637726
Completed
Not Applicable

Bispectral Index Under Propofol Anesthesia in Children : a Comparative Randomised Study Between TIVA and TCI

Pr Isabelle CONSTANT1 site in 1 country66 target enrollmentFebruary 2006

Overview

Phase
Not Applicable
Intervention
Remifentanil
Conditions
Anesthesia
Sponsor
Pr Isabelle CONSTANT
Enrollment
66
Locations
1
Primary Endpoint
Percentage of time spent at adequate BIS values
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

In children, only a few studies have compared different modes of propofol infusion during a total intravenous anesthesia (TIVA) with propofol and remifentanil. The aim of this study is to compare Bispectral Index (BIS) profiles (percentage of time spent at adequate BIS values) between four modes of propofol infusion: titration of the infusion rate on clinical signs (TIVA0), titration of the infusion rate on the BIS (TIVABIS), target controlled infusion (TCI) guided by the BIS either with the Kataria model (TCI KBIS) or the Schnider model (TCI SBIS).

Methods: Children will be prospectively randomized into the 4 groups. In the TIVA0 group the anesthesiologist is blinded to the BIS. In each group, the percentage of time with adequate BIS values (45-55), the bias and imprecision will be calculated.

Registry
clinicaltrials.gov
Start Date
February 2006
End Date
March 2007
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pr Isabelle CONSTANT
Responsible Party
Sponsor Investigator
Principal Investigator

Pr Isabelle CONSTANT

Professor Isabelle Constant

Hôpital Armand Trousseau

Eligibility Criteria

Inclusion Criteria

  • weighting more than 15 kg;
  • American Society of Anesthesiologists physical status I or II
  • scheduled for middle ear surgery

Exclusion Criteria

  • cardiovascular, neurological, hepatic or renal impairment, if their body mass index was above 95th percentile or if they received any drug interfering with the central nervous system.

Arms & Interventions

TIVA0

Propofol : TIVA guided by clinical signs. Remifentanil

Intervention: Remifentanil

TIVA BIS

propofol : TIVA guided by EEG Monitoring. Remifentanil

Intervention: EEG Monitoring

TIVA BIS

propofol : TIVA guided by EEG Monitoring. Remifentanil

Intervention: Remifentanil

TCI KBIS

Propofol : TCI Kataria guided by EEG Monitoring. Remifentanil.

Intervention: EEG Monitoring

TCI KBIS

Propofol : TCI Kataria guided by EEG Monitoring. Remifentanil.

Intervention: Remifentanil

TCI SBIS

Propofol : TCI Schnider guided by EEG Monitoring. Remifentanil.

Intervention: EEG Monitoring

TCI SBIS

Propofol : TCI Schnider guided by EEG Monitoring. Remifentanil.

Intervention: Remifentanil

Outcomes

Primary Outcomes

Percentage of time spent at adequate BIS values

Time Frame: from the beginning to the end of the anesthesia

Study Sites (1)

Loading locations...

Similar Trials